The purpose of this program is to provide training at the postdoctoral level in the disciplines of protein chemistry, cell biology, molecular biology, developmental biology, immunology, neuroscience or genetics as they relate to the etiology and pathogenesis of blood disorders and cancer. Trainees are individuals with motivation and a scholarly background, particularly in research. Trainees will be accepted into the program for a minimum of two years, except under unusual circumstances. Most trainees will be MDs with at least 2 (and usually 3 or 4) years of training in Pediatrics or Internal Medicine, and also clinical training in Hematology and/or Oncology. Many of the MD candidates will have had previous research experience including graduation from combined MD/PhD programs. Occasional trainees are recent graduates of PhD programs who are interested in postdoctoral research related to blood diseases. We are particularly interested in attracting minority candidates. It is expected that all trainees will acquire PhD-equivalent research experience and that many will acquire additional training equivalent to a PhD postdoctoral experience. The program of training will take place in our own laboratories and in laboratories throughout the Boston biomedical community under the guidance of outstanding and experienced preceptors. Many of these laboratories are in a hospital environment and many of the preceptors and trainees will have clinical training. This encourages correlation of basic laboratory studies with current health problems, especially related to blood disorders. Training will also include participation in didactic courses, attendance at formal lectures and seminars, involvement with relevant research literature, practice in oral presentation, and frequent informal conferences and evaluations of the trainees' ongoing research.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007574-26
Application #
7252467
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Chang, Henry
Project Start
1975-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
26
Fiscal Year
2007
Total Cost
$618,131
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Feraco, Angela M; Brand, Sarah R; Gagne, Joshua et al. (2018) Development of the ""Day 100 Talk"": Addressing existing communication gaps during the early cancer treatment period in childhood cancer. Pediatr Blood Cancer 65:e26972
De Vita, Serena; Li, Yanhua; Harris, Chad E et al. (2018) The gp130 Cytokine Interleukin-11 Regulates Engraftment of Vav1-/- Hematopoietic Stem and Progenitor Cells in Lethally Irradiated Recipients. Stem Cells 36:446-457
Gansner, John M; Furutani, Elissa; Campagna, Dean R et al. (2018) Pancreatic lipomatosis in Diamond-Blackfan anemia: The importance of genetic testing in bone marrow failure disorders. Am J Hematol 93:1194-1195
Khajuria, Rajiv K; Munschauer, Mathias; Ulirsch, Jacob C et al. (2018) Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell 173:90-103.e19
Bliss-Moreau, Meghan; Chen, Alyce A; D'Cruz, Akshay A et al. (2017) A motive for killing: effector functions of regulated lytic cell death. Immunol Cell Biol 95:146-151
Rowe, R Grant; Daley, George Q (2017) Stem cells: Valine starvation leads to a hungry niche. Nature 541:166-167
Feraco, Angela M; Dussel, Veronica; Orellana, Liliana et al. (2017) Tumor Talk and Child Well-Being: Perceptions of ""Good"" and ""Bad"" News Among Parents of Children With Advanced Cancer. J Pain Symptom Manage 53:833-841
Sexauer, Amy N; Tasian, Sarah K (2017) Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia. Front Pediatr 5:248
Fiorini, Claudia; Abdulhay, Nour J; McFarland, Sean K et al. (2017) Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice. Am J Hematol 92:E513-E519
Al-Herz, Waleed; Chu, Julia I; van der Spek, Jet et al. (2016) Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 138:852-859.e3

Showing the most recent 10 out of 81 publications